Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05734716 · ClinicalTrials.gov registry record · Phase 4
Colorado-Oregon Altitude Study
A Phase 4 study, sponsored by University of Oregon.
- Completed
- Registry status
- Phase 4
- Development phase
- 121
- Enrollment target
NCT05734716: Completed Phase 4 study, sponsored by University of Oregon.
NCT05734716 is a Phase 4 study that has completed, run by University of Oregon. The registered enrollment target is 121 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05734716, a Phase 4 study, has completed, sponsored by University of Oregon.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 121 participants
- Enrollment target
Study Summary
Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
Primary Outcome
Lake Louise Score of Acute Mountain Sickness symptoms
Interventions
- DRUG Sterile Sodium Chloride
- DRUG Erythropoietin
- DRUG Iron sucrose (Venofer)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 121 participants |
| Start Date | 2021-02-17 |
| Est. Completion | 2023-01-01 |
| Phase | Phase 4 |
What the finished NCT05734716 record still lists
NCT05734716 is an interventional study that assigns participants to a tested intervention. The registered 121 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 3 interventions - of which Sterile Sodium Chloride is the first listed.
NCT05734716 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05734716 about?
NCT05734716 is a clinical study titled "Colorado-Oregon Altitude Study". Investigating the utility of prophylactic treatment with iron sucrose and/or erythropoietin on the prevention of acute mountain sickness in fit, young, healthy individuals.
What is the current status of trial NCT05734716?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 121 participants. The study started on 2021-02-17. Estimated completion is 2023-01-01.
What interventions are being tested in trial NCT05734716?
The interventions under investigation include: Sterile Sodium Chloride (DRUG), Erythropoietin (DRUG), Iron sucrose (Venofer) (DRUG).
Who is sponsoring clinical trial NCT05734716?
This trial is sponsored by University of Oregon, which has 63 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05734716's enrollment target sits among peer trials
121 669th of 2000 higher than 1,328 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03476681 · 121 participants · Phase 1
Study of NEO-201 in Solid Tumors Expansion Cohorts
- NCT04655118 · 121 participants · Phase 2
Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis
- NCT04676802 · 121 participants · Phase 2
Pain Relief After Trapeziectomy: Ibuprofen & Acetaminophen Versus Oxycodone
- NCT05169515 · 121 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI